What is Arcutis Biotherapeutics, Inc.'s debt repayments?

Arcutis Biotherapeutics, Inc. (ARQT) reported debt repayments of $0 in Q4 2025.

How has Arcutis Biotherapeutics, Inc.'s debt repayments changed year-over-year?

Arcutis Biotherapeutics, Inc.'s debt repayments decreased by 100.0% year-over-year, from $25M to $0.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Arcutis Biotherapeutics, Inc. ARQT Debt Repayments

Debt Repayments at other companies

AmgenAMGN

$833M-66.7%

OrganonOGN

$32M-65.6%

LQD

Liquidia CorporationLQDA

$19.97M+841%

Rhythm Pharmaceuticals, Inc.RYTM

$4.29M-7.1%

BridgeBio PharmaBBIO

$0-100%

Bristol-Myers SquibbBMY

$500M—

Other financials

Income statement

See full

Revenue$105.4M+60.1%

Gross profit$95.6M+67.7%

Operating income-$9.1M+62.9%

Net income-$11.3M+54.9%

EPS (diluted)-$0.09+55.0%

Balance sheet

See full

Cash & equivalents$35.1M-34.7%

Total debt$114.7M+3.5%

Total equity$189.6M+32.9%

Total assets$460.0M+33.7%

Cash flow

See full

Operating cash flow$2.2M+107%

CapEx--100%

Free cash flow$2.2M+107%

Valuation

See full

Market cap$3.28B+57.5%

Enterprise value$3.36B+57.0%

P/S7.9×-1.9×

Profitability

See full

Gross margin90.9%+2.5pp

Operating margin-12%-5.7pp

Net margin-13.9%-6.6pp

FCF margin-52.5%-21.9pp

Returns & leverage

See full

Return on equity-28.2%-13.0pp

Debt / equity0.6×-0.2×

Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Arcutis Biotherapeutics, Inc.’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s debt repayments?: Arcutis Biotherapeutics, Inc. (ARQT) reported debt repayments of $0 in Q4 2025.
How has Arcutis Biotherapeutics, Inc.'s debt repayments changed year-over-year?: Arcutis Biotherapeutics, Inc.'s debt repayments decreased by 100.0% year-over-year, from $25M to $0.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.